tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Pete Stavropoulos, 26 are a BUY (100%).
Analyst Pete Stavropoulos, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 38.33% that have a potential upside of 103.51% achieved within 194 days.
Pete Stavropoulos’s has documented 47 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANNX, Annexon at 15-Nov-2024.
Analyst best performing recommendations are on ORTX (ORCHARD THERAPEUTICS PLC).
The best stock recommendation documented was for ORTX (ORCHARD THERAPEUTICS PLC) at 6/27/2023. The price target of $15 was fulfilled within 100 days with a profit of $9.77 (186.81%) receiving and performance score of 18.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8 days ago
(15-Nov-2024)
0/5 (0%)
$10.05 (340.68%)
Buy
$16
$10.7 (201.89%)
$16
8 days ago
(15-Nov-2024)
0/11 (0%)
$9.83 (159.32%)
Buy
$30
$24.7 (466.04%)
$30
8 days ago
(15-Nov-2024)
0/7 (0%)
$23.83 (386.22%)
Buy
$13
$7.7 (145.28%)
$11
7 months 22 days ago
(01-Apr-2024)
1/4 (25%)
$6.37 (96.08%)
188
Buy
$10
$4.7 (88.68%)
$6
7 months 26 days ago
(28-Mar-2024)
4/5 (80%)
$2.83 (39.47%)
106
Which stock is Pete Stavropoulos is most bullish on?
Which stock is Pete Stavropoulos is most reserved on?
What Year was the first public recommendation made by Pete Stavropoulos?
